As per the available reports of about 10 Journals, 13 Conferences, 5 National Symposium and seven open access articles published by the OMICS International related to the chemotherapeutic agent.

 

Chemotherapeutic agents act by killing cells that divide rapidly, one of the main properties of most cancer cells. This means that chemotherapy also harms cells that divide rapidly under normal circumstances: cells in the bone marrow, digestive tract, and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract),and alopecia (hairloss).

Cancer chemotherapy is the use of drugs to kill cancer cells. Unlike radiation therapy and surgery, which are localized treatments, chemotherapy is a systemic treatment, meaning the drugs travel throughout the whole body. This means chemotherapy can reach cancer cells that may have metastasized to other areas. Chemotherapy can also be delivered by IV through catheters, ports, and pumps. A catheter is a soft, thin, flexible tube that is placed in a large vein in the body. It remains in place as long as necessary. Sometimes the catheter is attached to a port, which is a small round plastic or metal disc placed under the skin. In those with certain types or advanced cancers that are resistant to treatment, cachexia is possible. Cachexia, or wasting, is a significant loss of weight and muscle mass, which can occur without loss of appetite or decreased intake of calories. Treating the cancer is the most effective way to overcome cachexia. Dietary changes or medications have little effect on regaining lost weight.

In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to a new report.

The National Institutes of Health estimated the overall costs of cancer in 2010 at $263.8 billion, of which $102.8 billion was for direct medical costs (total of all health expenditures), $20.9 billion for loss of productivity due to illness and $140.1 billion for cost of lost productivity due to premature death. In 2004, Medicare payments for all Part B drugs for medical oncology reached a total of $5.3 billion (of $2.3 billion for chemotherapy and $1.5 billion for erythroid growth factors). A 2007 study said that drugs prescribed by oncologists account for more than 40% of medicare spending, and spending on oral chemotherapy drugs as a proportion of total pharmacy benefits costs more than doubled between 2002 and 2006, increasing from 0.3% to 0.7%. 

 

 International Conferences

1· 4^th Cancer Diagnostic Conference,
    June 13-15, 2016,Rome,Italy.

2· 6^th Cancer Therapy Conference,
    September 28-30 , Atlanta ,USA.

3· Pancreatic Cancer and Colorectal Cancer Conference
    March 29-30,Atlanta,USA.

4· Blood Malignancies Conference,
    April 18-20,2016,Dubai,UAE.

5· 2^nd Prostate cancer Conference,
    May 5-7,Chicago,USA.

6·  Gynecologic oncology conference,
    May 19-21 ,2016, San Antigo,USA.

7· 10^th Oncologist Conference,
     July 11-13,2016, Cologne.

8· 11^th Oncologist Conference,
     July 11-13 , Kaula Lumpur, Malaysia.

9· Pediatric Oncology Conference,
     August 4-6 ,2016 , Toronto, Canada.

10· Molecular Biomarkers and Cancer Biomarkers Conference
      September 15-17,2016 , Berlin, Germany.

11· Surgical Oncology Conference,
      September1-3,2016 , Sao Paulo,Brazil.

12· Leukemia and Bone Marrow Transplantation Conference,
       November 10-12, Istanbul,Turkey.

13·5^th Cancer Therapy Conference,
      September 28-30,Atlanta,USA.

14·  4^th Toxicology Conference,
       September19-21,Las Vegas,USA.

15· Antimicrobial Agents and Chemotherapy Conference,
      June 6-7, 2016, Dallas,USA.

16· Oral, Mouth and Throat Cancer Conference
      August 18-20 ,2016,Portland,USA.

17·  Radiologist Conference,
       March 17-18 ,2016 .London ,UK

18· Biomarker and Clinical Research Conference,
      August 31-Sep 2,2016 ,Toronto, Canada.

19· 3^rd Genomics and Pharmacogenomics Conference,
      September 21-23, San Antigo,USA.

20· Clinical and Molecular Genetics Conference,
       November 28-30 ,2016, Chicago , USA.

21·4^th  Immunology Conference,
      September 28-30 ,2016, Houston, USA.

22· ACCRA Cancer Conference,
      Sep 3-5 ,2015, ACCRA ,Ghana

23· Cancer Diagnosis &Therapy Conference
      Sep3-5 ,2015,London,UK

24·  25^th World Congress on Lymphology,
       Sep 7-11 ,2015 ,San Francisco,USA

25·  3^rd International Oncology Conference,
        Sep 10-11 ,2015,Abu Dhabi,UAE

26·  Chinese Society of Clinical Oncology-Annual Meeting,
       Sep 16-20,Sep 2015,Xiamen,China.

27·  4^th European Congress on Immunology,
       Sep 6-9,2015 , Vienna ,Austria.

28·  3^rd Annual Congress of the European Society for Translational Medicine,
       Sep 1-4 ,2015 Vienna,Austria.

• International Society of Chemotherapy for Infection and Cancer

• American Cancer Society

• The British Society for Antimicrobial Chemotherapy

• European Society of Clinical Microbiology and Infectious Diseases

• American Society of Clinical Oncology

• African Society of Chemotherapy

• Federation of the European Societies of Chemotherapy and Infection

• Oncology Nursing Society

• Oral Chemotherapy Management- Florida Society of Health

 

The National Institutes of Health estimated the overall costs of cancer in 2010 at $263.8 billion, of which $102.8 billion was for direct medical costs (total of all health expenditures), $20.9 billion for loss of productivity due to illness and $140.1 billion for cost of lost productivity due to premature death.

 

• Markansan Pharma Ltd

• MedIndia-Network for Health

• Sanofi-Aventis

• Eli Lilly & Company

• Schering-Plough

• Leerink Swann

• SHC & Associates

• DuPont Merck Pharmaceutical Company

• Strativa Pharmaceuticals

• Spectrum Pharmaceuticals

• Roche

• Novartis

• Celgene

• Astrazenca

• Merck &Co.

• Pfizer

• Astellas

• Bayer

• Sanofi

• Eisai

• Pharmacyclis